Joanna Horobin

KYMR

Joanna Horobin serves as Director at Kymera Therapeutics, Inc. (KYMR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$416.3K

Net Position

Net Seller

$416.3K

Companies Traded

LQDA, KYMR

Active Period

Jun 2024 – Aug 2025

2 total trades

Most Recent

Sell LQDA

Aug 19, 2025 · $135.8K

Joanna Horobin's Insider Trading at Kymera Therapeutics, Inc. (KYMR)

Buys

0 · $0.00

Sells

1 · $280.4K

Total Shares Bought

Total Shares Sold

8,500

KYMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 7, 2024↗	Sell	8,500	$32.99	$280.4K	6,313

Joanna Horobin's Insider Trading at Liquidia Corporation (LQDA)

Buys

0 · $0.00

Sells

1 · $135.8K

Total Shares Bought

Total Shares Sold

5,000

LQDA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 19, 2025↗	Sell	5,000	$27.17	$135.8K	0

Related Insiders

Jeremy G Chadwick

officer: Chief Operating Officer

KYMRSell · Mar 11, 2026

Scott Moomaw

officer: Chief Commercial Officer

LQDASell · Mar 9, 2026

Jared Gollob

officer: Chief Medical Officer

KYMRSell · Mar 4, 2026

Bruce N. Jacobs

officer: Chief Financial Officer

KYMRSell · Mar 4, 2026

Michael Kaseta

officer: CFO and COO

LQDASell · Mar 2, 2026

Bruce Booth

director

KYMRSell · Mar 2, 2026

Dana Boyle

officer: Chief Accounting Officer

LQDASell · Mar 2, 2026

Jason Adair

officer: Chief Business Officer

LQDASell · Mar 2, 2026

Explore More Insider Trading Data

KYMR Insider Trading Activity

View all insider trades at Kymera Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity